Try
MANNKIND CORP
MNKDUnited States
54 filed reports · 885 financial concepts · 0 earnings calls · 0 media appearances
Filed reports
54 reports · Mar 2013 to Jun 2026Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 40 | 6,841 | Mar 2013 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 13 | 6,644 | Dec 2013 to Dec 2025 |
| Quarterly · 10-Q/ASEC EDGAR | 1 | 108 | Jun 2016 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Aug 5, 2026 | 504 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 6, 2026 | 329 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Feb 26, 2026 | 1,151 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Nov 5, 2025 | 334 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Aug 6, 2025 | 225 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 8, 2025 | 223 | Open |
| FY2024 | 10-K | Dec 31, 2024 | Feb 26, 2025 | 540 | Open |
| FY2024 Q3 | 10-Q | Sep 30, 2024 | Nov 7, 2024 | 241 | Open |
| FY2024 Q2 | 10-Q | Jun 30, 2024 | Aug 7, 2024 | 217 | Open |
| FY2024 Q1 | 10-Q | Mar 31, 2024 | May 8, 2024 | 233 | Open |
| FY2023 | 10-K | Dec 31, 2023 | Feb 27, 2024 | 572 | Open |
| FY2023 Q3 | 10-Q | Sep 30, 2023 | Nov 7, 2023 | 220 | Open |
Financial data
885 concepts · 13,593 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial860 concepts · 12,985 facts · Feb 1992 to Jul 2026
- Stockholders equity (US GAAP)110 · Feb 1992 to Jun 2026
- Net income loss93 · Feb 1992 to Jun 2026
- Cash and cash equivalents at carrying value76 · Dec 2010 to Jun 2026
- 202675 · Dec 2016 to Jun 2026
- Allocated share based compensation expense73 · Dec 2011 to Jun 2026
- Common stock shares authorized73 · May 2012 to Jun 2026
- Comprehensive income net of tax73 · Dec 2011 to Jun 2026
- Depreciation and amortization73 · Dec 2011 to Jun 2026
- Increase decrease in accounts payable73 · Dec 2011 to Jun 2026
- Increase decrease in accrued liabilities and other operating liabilities73 · Dec 2011 to Jun 2026
- Increase decrease in prepaid deferred expense and other assets73 · Dec 2011 to Jun 2026
- Investment income interest73 · Dec 2011 to Jun 2026
- Operating income loss73 · Dec 2011 to Jun 2026
- Research and development expense excluding acquired in process cost73 · Dec 2011 to Jun 2026
- Share based compensation73 · Dec 2011 to Jun 2026
- Common stock shares outstanding71 · Feb 2012 to Jun 2026
- Accounts payable current69 · Dec 2012 to Jun 2026
- Accrued liabilities current69 · Dec 2012 to Jun 2026
- Accumulated depreciation depletion and amortization property plant and equipment69 · Dec 2012 to Jun 2026
- Additional paid in capital common stock69 · Dec 2012 to Jun 2026
- Assets69 · Dec 2012 to Jun 2026
- Assets current69 · Dec 2012 to Jun 2026
- Common stock par or stated value per share69 · Dec 2012 to Jun 2026
- Common stock shares issued69 · Dec 2012 to Jun 2026
Product10 concepts · 392 facts · Mar 2016 to Jun 2026
- Revenue197 · Mar 2016 to Jun 2026
- Accounts Receivable, Net52 · Jun 2021 to Jun 2026
- Operating expenses (US GAAP)51 · Dec 2020 to Jun 2026
- Cost of revenue (US GAAP)45 · Dec 2016 to Jun 2026
- Insulin20 · Dec 2017 to Dec 2022
- AFREZZA product sales12 · Mar 2016 to Dec 2017
- Sagard6 · Dec 2023 to Mar 2026
- Tyvaso DPI6 · Dec 2023 to Mar 2026
- Other sales revenue net2 · Mar 2017 to Dec 2017
- Net revenue - collaboration1 · Dec 2016
Segment15 concepts · 216 facts · Dec 2022 to Jun 2026
- Revenue73 · Dec 2022 to Jun 2026
- Cost of goods and services sold (US GAAP)14 · Dec 2022 to Jun 2026
- Cost of revenue (US GAAP)14 · Dec 2022 to Jun 2026
- General and administrative expense (US GAAP)14 · Dec 2022 to Jun 2026
- Interest expense (US GAAP)14 · Dec 2022 to Jun 2026
- Investment income interest14 · Dec 2022 to Jun 2026
- Net income loss14 · Dec 2022 to Jun 2026
- Research and development expense excluding acquired in process cost14 · Dec 2022 to Jun 2026
- Selling expense14 · Dec 2022 to Jun 2026
- Other Significant Segment7 · Dec 2023 to Jun 2026
- Impairment of long lived assets to be disposed of6 · Dec 2023 to Dec 2025
- Nondebtor reorganization items net gain loss on settlement of other claims16 · Jun 2024 to Jun 2026
- Segment reporting other item amount6 · Mar 2024 to Sep 2025
- Amortization of intangible assets3 · Dec 2025 to Jun 2026
- Other expenses3 · Dec 2022 to Dec 2024
Segments
608 factsFigures broken down by business line, region, product or another axis the company reports on.
Product or servicesrt:ProductOrServiceAxis17 members · 373 facts
- License And Service83 · Dec 2016 to Jun 2026
- Service50 · Dec 2020 to Jun 2026
- Product47 · Dec 2016 to Jun 2026
- Product Revenue34 · Dec 2021 to Jun 2026
- Product Sales26 · Dec 2020 to Sep 2023
- License and service26 · Jun 2021 to Jun 2026
- Product26 · Jun 2021 to Jun 2026
- Royalty21 · Jun 2022 to Jun 2026
- Insulin17 · Dec 2018 to Dec 2022
- Tyvaso DPI12 · Dec 2023 to Mar 2026
- Manufacturing Services11 · Dec 2023 to Mar 2026
- Product And Service Other7 · Dec 2016 to Sep 2018
- License4 · Jun 2017 to Sep 2018
- Collaborations And Services Related To Tyvaso DPI3 · Mar 2024 to Mar 2026
- Commercial Related To Afrezza And Vgo3 · Mar 2024 to Mar 2026
- Bulk Insulin Sales And Sale Of Intellectual Property2 · Jun 2017 to Sep 2017
- Bulk Insulin Sales1 · Dec 2017
Statement business segments1 member · 216 facts
- All Other Segments216 · Dec 2022 to Jun 2026
Product or serviceus-gaap:ProductOrServiceAxis3 members · 19 facts
- Product13 · Mar 2016 to Dec 2017
- Insulin4 · Dec 2016 to Mar 2018
- Bulk Insulin Sales2 · Mar 2017 to Dec 2017
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
Transcripts with management claims and analyst questions, one per fiscal period.
No earnings-call transcripts for this company.
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.